tradingkey.logo
tradingkey.logo
検索

MiMedx Group Inc

MDXG
ウォッチリストに追加
3.930USD
+0.120+3.15%
終値 06/26, 16:00ET15分遅れの株価
582.01M時価総額
18.91直近12ヶ月PER

詳細情報 MiMedx Group Inc 企業名

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.

MiMedx Group Incの企業情報

企業コードMDXG
会社名MiMedx Group Inc
上場日Aug 20, 2007
最高経営責任者「CEO」Capper (Joseph H)
従業員数837
証券種類Ordinary Share
決算期末Aug 20
本社所在地1775 W Oak Commons Court, Ne
都市MARIETTA
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号30062
電話番号17706519100
ウェブサイトhttps://mimedx.com/
企業コードMDXG
上場日Aug 20, 2007
最高経営責任者「CEO」Capper (Joseph H)

MiMedx Group Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%

よくある質問

MiMedx Group Incの上位5名の株主は誰ですか?

MiMedx Group Incの上位5名の株主は以下のとおりです。Mr. Joseph H. (Joe) Capper

MiMedx Group Inc(MDXG)の株式を保有している機関の数はいくつですか?

2026Q1時点で、MiMedx Group Incの株式を保有している機関は462社あり、保有株式の総市場価値は約116.77Mで、全体の78.40%を占めています。2025Q4と比較して、機関の持ち株は6172968.00増加しています。

MiMedx Group Incの最大の収益源は何ですか?

2026Q1において、Advanced Wound Care部門がMiMedx Group Incにとって最大の収益を生み出しており、その金額は276.33Mで、全収益の66.01%を占めています。
KeyAI